Chemoinformaics analysis of
15-O-acetylbruceolide
| Molecular Weight | 480.466 | nRot | 2 |
| Heavy Atom Molecular Weight | 452.242 | nRig | 28 |
| Exact Molecular Weight | 480.163 | nRing | 5 |
| Solubility: LogS | -3.094 | nHRing | 2 |
| Solubility: LogP | 0.01 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 0 |
| nHA | 11 | APOL | 65.9022 |
| nHD | 3 | BPOL | 38.5058 |
| QED | 0.281 |
| Synth | 6.449 |
| Natural Product Likeliness | 3.517 |
| NR-PPAR-gamma | 0.55 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.994 |
| Pgp-sub | 0.55 |
| HIA | 0.868 |
| CACO-2 | -5.321 |
| MDCK | 0.0000931 |
| BBB | 0.624 |
| PPB | 0.307342 |
| VDSS | 0.351 |
| FU | 0.649158 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.718 |
| CYP2c19-inh | 0.007 |
| CYP2c19-sub | 0.681 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.04 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.115 |
| CYP3a4-inh | 0.099 |
| CYP3a4-sub | 0.239 |
| CL | 3.166 |
| T12 | 0.099 |
| hERG | 0.002 |
| Ames | 0.021 |
| ROA | 0.525 |
| SkinSen | 0.012 |
| Carcinogencity | 0.047 |
| EI | 0.007 |
| Respiratory | 0.083 |
| NR-Aromatase | 0.012 |
| Antiviral | Yes |
| Prediction | 0.759779 |